InvestorsHub Logo
Followers 70
Posts 7713
Boards Moderated 0
Alias Born 09/28/2012

Re: Neuronal post# 41882

Sunday, 08/04/2013 1:13:28 PM

Sunday, August 04, 2013 1:13:28 PM

Post# of 194800
It is his plan to uplist. Likely an RS is required at this point maybe in 2014. However, marketing, product distribution and positive cash flow must come first.

I still like the vertical approach they are taking. It will outperform fitx competitors in the market which leads to lower prices with better margins on sales. Bill knows supplements are almost a commodity in a flooded market. It's about competitive results and lower prices. Trying to dominate a market is not the goal. The goal is to marginally outperform and have diversified revenue streams targeting different demographics. Licensing formulations is a great method for dealing with regulations as well.

I personally love the strategy.